The GLP-1/Notch signaling pathway controls the proliferation vs. meiotic entry decision in the C. elegans germ line. GLP-1/Notch signaling promotes proliferation by negatively regulating two redundant downstream pathways (GLD-1, NOS-3/GLD-2, GLD-3), which inhibit proliferation and/or promote meiotic entry. To identify genes that function in the GLD-1 pathway a mutant screen in a
gld-2(0) background was performed. The
oz237 allele was identified in this screen as being synthetically tumourous with
gld-2(0). We have mapped
oz237 to a 40 kB region between
lst-1 and
tli-1 on Chromosome I in the C. elegans genome. There are 14 genes in this region; we used RNAi and sequenced candidate genes to determine the gene corresponding to the
oz237 allele. A mutation was discovered in the coding region of
pas-5 (Proteasome Alpha Subunit). An extrachromasomal array containing full length WT
pas-5 can partially rescue the germ line phenotype in the
oz237 mutants, suggesting the lesion in
pas-5 is the
oz237 allele.
pas-5(
oz237) is likely reducing proteasome activity since conventional RNAi to
pas-5 causes embryonic lethality but low dose RNAi can phenocopy the
pas-5(
oz237);
glp-1(gf) germline phenotype. To help identify the protein or proteins that are not being degraded properly in the
pas-5(
oz237) mutant we determined if it interacts with other Notch regulated cell fate decisions.
pas-5 may act as a general negative regulator of Notch signaling since the
oz237 mutant can enhance the multi-vulva phenotype of two weak gain-of-function mutations of
lin-12(Notch). It also causes a multi-vulva phenotype with
sel-10(0), an F-Box protein thought to target LIN-12(INTRA) to the proteasome. We also performed epistasis experiments with other regulators of the proliferation vs. differentiation decision in the germ line. Along with being synthetic tumourous with
gld-2(0),
pas-5(
oz237) is also synthetic tumourous with
gld-3(0). When GLP-1 activity is removed from the
gld-2 pas-5(
oz237) tumourous double mutant, the animals are no longer tumourous, but rather have the premature meiotic entry Glp phenotype. This interaction suggests
pas-5 may function genetically upstream of Notch signaling. However when GLP-1 activity is removed from the
pas-5(
oz237);
gld-3 double mutant the germ line remains tumourous; however the tumor is not as robust as in the double mutant. This suggests that
gld-2 and
gld-3 have separate functions in relation to the
pas-5(
oz237) mutation when involved in the mitosis vs. meiosis decision in the germ line.